Follistatin Myostatin Inhibitor
A natural inhibitor of myostatin and activin studied for skeletal muscle growth and connective-tissue effects.
Book Free ConsultationCall 310.299.4444What Follistatin actually is
Follistatin is an endogenous protein that binds and inhibits myostatin (GDF-8) and activin A — both of which suppress skeletal muscle growth. Loss-of-function myostatin mutations produce the well-known ‘double-muscled’ phenotype in cattle and dogs, and a single human case report shows similar hypertrophy.1
Follistatin-344 and Follistatin-315 are the most-studied forms in peptide practice. Gene-therapy approaches with follistatin have shown striking muscle-mass effects in dystrophy models, but peptide-form follistatin has more modest and less well-characterized human data.2
At Luxbae, Follistatin is prescribed and supervised by Dr. Ernst von Schwarz, MD, PhD after a complimentary medical consultation.
Mechanism — Myostatin and activin sequestration
Binds circulating myostatin/activin A with high affinity, blocking their suppressive effects on muscle protein synthesis.1
What the research shows
Myostatin antagonism. Sequesters myostatin to release the brake on muscle protein synthesis.1
Hypertrophy signal. Striking effects in animal models and gene-therapy trials.2
Connective tissue. Activin A inhibition has broader effects on fibrosis and tissue remodeling.3
Side effects: Limited human data. Injection-site reactions, possible fluid retention, theoretical effects on cardiac and other smooth muscle.
FDA note: Follistatin is not FDA-approved. Gene-therapy approaches are in clinical trials for muscular dystrophy. Peptide use is investigational.
Follistatin FAQ
Will I gain noticeable muscle?
Animal and gene-therapy data are striking; peptide-form human data is more modest.
Is this safe?
Long-term human peptide data is limited. We use cycles and monitor.
References
- Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross muscle hypertrophy. N Engl J Med. 2004;350(26):2682-2688.
- Mendell JR, Sahenk Z, Al-Zaidy S, et al. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis. Mol Ther. 2017;25(4):870-879.
- Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol. 2004;20:61-86.
